We’re one step closer to a malaria-free world
Now that malaria has been eliminated in China, the long-held dream of a malaria-free world is one nation closer to reality.
Moderna launches human trial for mRNA flu vaccine
Moderna Therapeutics is trialing an mRNA flu vaccine in humans and developing one to protect against seasonal influenza and COVID-19.
Oxford launches HIV vaccine trial
The University of Oxford’s newly launched HIV vaccine trial will test a unique approach to protecting people against the AIDS-causing virus.
“LEGO-like” vaccine protects mice from COVID, SARS, MERS, and variants
Using a “chimeric” spike protein, researchers have immunized mice against multiple types of coronaviruses with one shot.
We may have a new ally in the fight against dengue fever
A large trial has provided the best evidence yet that infecting mosquitoes with Wolbachia can help reduce dengue infections.
A virus "chimera" reveals new dengue targets
Using a flavivirus that only infects insects, Australian researchers can safely study more dangerous viruses.
Did the flu lose diversity during the pandemic?
After a record-low flu season, an entire clade of flu may be gone. If so, making vaccines may have become easier.
Inhaled CRISPR treatment tackles COVID-19, flu
An inhaled CRISPR treatment can be easily tweaked to attack a variety of viruses, from the one that causes the flu to the coronavirus behind COVID-19.
Predicting your protection against COVID-19
Australian researchers have found an immune response measurement they believe can predict protection against COVID-19.